Eisai
4523.T
#2232
Rank
S$10.65 B
Marketcap
S$37.76
Share price
-0.93%
Change (1 day)
-1.95%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): S$1.14

According to Eisai's latest financial reports the company's current EPS (TTM) is S$1.12. an increase over its 2024 EPS that were of S$1.26.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025S$1.4111.85%
2024S$1.26-32.63%
2023S$1.875.52%
2022S$1.77-74.01%
2021S$6.82-66.58%
2020S$20.4198.24%
2019S$10.3017.01%
2018S$8.8037.78%
2017S$6.39-27.62%
2016S$8.8235.33%
2015S$6.52-2.82%
2014S$6.71-27.66%
2013S$9.28-27.49%
2012S$12.79-12.67%
2011S$14.6588.08%
2010S$7.79-11.06%
2009S$8.76-390.15%
2008S-$3.02-127.78%
2007S$10.8711.78%
2006S$9.724.38%
2005S$9.317.4%
2004S$8.6743.03%
2003S$6.0625.09%
2002S$4.8552.67%
2001S$3.1869.76%
2000S$1.87